Exchange: NASDAQ·Updated 07:47 PM EDT
MBOT logo

MBOT Microbot Medical Inc

$1.07
$0.00
(0.00%)
Today
Closed $1.07
$0.01
(0.94%)
After Hours
Mkt Cap$71.87M
Vol637,699.00

About MBOT

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
66

Bullish Sentiment

How do you feel about MBOT?

Growinspace
$MBOT Yeah, finally some good news, validation 👏, I'm in for another 10k shares, at this price, it'll double, 100%+ return in 12 months or less, hold if you own it, patience will be rewarded or buy if you can , glta
14
gladee88er
$MBOT It's hard to fathom where this was just 2 months ago with the exact same fundamentals. Shows you how brutal the market can be. Sometimes being patient can be a death sentence.
14
leLu83
$MBOT 11% short. 10 days to cover. Oversold. Any catalyst will bring massive buying pressure up to 2.00 in a single trading day.
12
leLu83
$MBOT took a little baby block and a half down here. Trading near cash. Market valuing entire company at 16.8M, fda approved device with plenty of cash to operate. Crazy. Will continue to add on weakness and RSI capitulation. Easy 💰 I made bank in 2019 on cvrs. Mazor robotics BO as well as isrg run up. Cash is worth $1.003 per share since last reporting (80% the stock price). Q3 burn will bring that to roughly $.92 (74% of the stock price) Fda approved device that fixes the capex for hospitals that were headwinds for cvrs. Prime acquisition target over next 9-18 mos by $SYK who previously JV with microbot. Medtronic is the front runner as they dominate the peripheral vascular and neurovascular space. As traction at hospitals increase disposables over the coming Qs, the larger med tech companies will BO microbot at a valuation of 450M - 600M with a maximum of 750M+ if adoption spreads rapidly. MDT, BSX, SYK, SHL, even Terumo could come calling 🚀
12
focafoca99
$MBOT announced its growth push, adding a second manufacturing line and expanding to 12 U.S. sales territories, including California.
11
Growinspace
$MBOT Hey, maybe 1 day soon we can be like medical device maker GCTK who SP just doubled overnight from $2 to $4+ this morning. MBOT hopefully soon will have good news to report and SP will jump from $1.30 to $2.60 +, wouldn't that be a positive green day instead of red days, fingers crossed ! Glta
9
NoItWasntMe
$MBOT Given that they likely spent several million in Q3, it seems reasonable to assume they have $60 million in the bank. The market is assuming the future opportunity is worth $20 mil. If they were to sell 8000 x $2,500 units in 2027 that is $20M. That would be 1/3rd of 1% penetration of their initial TAM in the US, with the only meaningful competition being manual techniques. Seems so attainable. Then again, with the sparse and 💩 ambiguous communications from the company, and seemingly slow initial chasm, 8000 may be a pipe dream. 🤷‍♂️ Can you tell I am annoyed? Ha ha
8
BobMacDTruck
$MBOT this will take time. As someone familiar with small medical device companies who are currently dealing with VAC approvals trying to get a new product into hospitals the process can be very slow even with compelling evidence.
7
GladysFoster
$MBOT hopefully it's in the process of being sold, would explain the organised slow grind down. 🤞one can dream
6
Growinspace
$MBOT Harel Gadot , CEO, we really need you to speak up here, now would be a good time ? Where are you ??
6
Samtosemi
$MBOT For those who think Adam Gefvert of White Diamond didn't fabricate his report on this company for greed. He leaned his entire report on his "anonymous sources", claiming that was the "gold" part of his piece, despite their inaccurate depiction of medical reimbursement. Adam backpedaled on his only named surgeon by attacking his credibility for denying Adam's quotes of him. Adam claimed Dr. Briggs did this "to be nice to the company", despite the legal trouble it would put Dr. Briggs in for testifying, within days of Adam's report, to using Liberty for the very medical procedures and wiring that Adam claimed the Dr. had said "liberty was incompatible with" and "not ready for". Adam may have libeled his named "source" Dr. Briggs as testifying to potentially negligent medical practice, "just to be nice to the company". Adam Gefvert made no further comment to which specific statements he disputes when legal implications of his response to Dr. Briggs’s rebuttal were raised.
4
blirp
$MBOT can we get some PR here. New hospital's every week then it just stops after earnings? Almost like it was intentional. WTF MBOT....
5
no_ego
$MBOT Geez! What happened here? The RSI section on my chart has to grow to make room for the extremely extreme oversold condition. I may buy back just to catch the bounce that resets the RSI.
4
NoItWasntMe
$MBOT Should we be on the lookout for another 💩 PR after market close right at the start of the weekend?
4
Lordlittle
$MBOT question is where is the bottom so my average will go down the most from it haha
4
Lordlittle
$MBOT to be honest this is a great spot for the people after a quick double your money when we get clearing for Europe that news will bring us massive gains for the stock but I do still expect it to fall again
3
StStephen72
$MBOT Sorry, PR is another "fluffer". Need sales not marketing agreements. Still holding now almost worthless Jan calls.
3
Eddypgil
$MBOT company still has many months of cash left so they can keep paying the executives extremely well
3
Lordlittle
$MBOT with the survey they posted you reckon the 48 people who did it were all surgeons using it? And if so how many surgery’s you reckon they did with it to actually judge it? Because if say they all have done 5 each that is 240 that like 390k revenue which weirdly enough matches the first two quarters of revenue atleast closely my argument at the end is if say they do 5 surgery all of them that atleast over a million dollars a quarter
3
Ahsgdg
$MBOT markets enterprise value is unchanged. What isnt unchanged is their cash balance that approximately accounts for over half of their market cap. This means as their cash loses value from operating expenses, market cap will also drop over time. That is what is happening right now
3

Advertisement|Remove ads.